Correction: Clusterin confers gemcitabine resistance in pancreatic cancer

After the publication of this work [1], we noticed that we had incorrectly used the term 'OGX-011'. All instances of OGX-011 in the manuscript should be changed to 'ASO-CLU'.We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it.

via World Journal of Surgical Oncology